Cystic fibrosis: An inherited disease affecting mucin-producing organs

被引:80
作者
Ehre, Camille [1 ]
Ridley, Caroline [2 ]
Thornton, David J. [2 ]
机构
[1] Univ N Carolina, CF Pulm Res & Treatment Ctr, Chapel Hill, NC 27514 USA
[2] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PL, Lancs, England
关键词
Mucin; Mucus; CF; CFTR; Pathogenesis; GEL-FORMING MUCIN; BACTERIAL OVERGROWTH; MUCUS GLYCOPROTEINS; TRACHEOBRONCHIAL MUCINS; ENDOPLASMIC-RETICULUM; OLIGOMERIC MUCINS; CFTR POTENTIATOR; SMALL-INTESTINE; LUNG-FUNCTION; MUC5B MUCINS;
D O I
10.1016/j.biocel.2014.03.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Our current understanding of cystic fibrosis (CF) has revealed that the biophysical properties of mucus play a considerable role in the pathogenesis of the disease in view of the fact that most mucus-producing organs are affected in CF patients. In this review, we discuss the potential causal relationship between altered cystic fibrosis transmembrane conductance regulator (CFTR) function and the production of mucus with abnormal biophysical properties in the intestine and lungs, highlighting what has been learned from cell cultures and animal models that mimic CF pathogenesis. A similar cascade of events, including mucus obstruction, infection and inflammation, is common to all epithelia affected by impaired surface hydration. Hence, the main structural components of mucus, namely the polymeric, gel-forming mucins, are critical to the onset of the disease. Defective CFTR leads to epithelial surface dehydration, altered pH/electrolyte composition and mucin concentration. Further, it can influence mucin transition from the intracellular to extracellular environment, potentially resulting in aberrant mucus gel formation. While defective HCO3- production has long been identified as a feature of CF, it has only recently been considered as a key player in the transition phase of mucins. We conclude by examining the influence of mucins on the biophysical properties of CF sputum and discuss existing and novel therapies aimed at removing mucus from the lungs. (C) 2014 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:136 / 145
页数:10
相关论文
共 123 条
  • [1] Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation
    Accurso, Frank J.
    Rowe, Steven M.
    Clancy, J. P.
    Boyle, Michael P.
    Dunitz, Jordan M.
    Durie, Peter R.
    Sagel, Scott D.
    Hornick, Douglas B.
    Konstan, Michael W.
    Donaldson, Scott H.
    Moss, Richard B.
    Pilewski, Joseph M.
    Rubenstein, Ronald C.
    Uluer, Ahmet Z.
    Aitken, Moira L.
    Freedman, Steven D.
    Rose, Lynn M.
    Mayer-Hamblett, Nicole
    Dong, Qunming
    Zha, Jiuhong
    Stone, Anne J.
    Olson, Eric R.
    Ordonez, Claudia L.
    Campbell, Preston W.
    Ashlock, Melissa A.
    Ramsey, Bonnie W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (21) : 1991 - 2003
  • [2] Altes T, 2012, PEDIATR PULM, V47, P291
  • [3] Calcium and pH-dependent packing and release of the gel-forming MUC2 mucin
    Ambort, Daniel
    Johansson, Malin E. V.
    Gustafsson, Jenny K.
    Nilsson, Harriet E.
    Ermund, Anna
    Johansson, Bengt R.
    Koeck, Philip J. B.
    Hebert, Hans
    Hansson, Gunnar C.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (15) : 5645 - 5650
  • [4] Function of the CysD domain of the gel-forming MUC2 mucin
    Ambort, Daniel
    van der Post, Sjoerd
    Johansson, Malin E. V.
    MacKenzie, Jenny
    Thomsson, Elisabeth
    Krengel, Ute
    Hansson, Gunnar C.
    [J]. BIOCHEMICAL JOURNAL, 2011, 436 : 61 - 70
  • [5] Human MUC5AC mucin dimerizes in the rough endoplasmic reticulum, similarly to the MUC2 mucin
    Asker, N
    Axelsson, MAB
    Olofsson, SO
    Hansson, GC
    [J]. BIOCHEMICAL JOURNAL, 1998, 335 : 381 - 387
  • [6] Dimerization of the human MUC2 mucin in the endoplasmic reticulum is followed by a N-glycosylation-dependent transfer of the mono- and dimers to the Golgi apparatus
    Asker, N
    Axelsson, MAB
    Olofsson, SO
    Hansson, GC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (30) : 18857 - 18863
  • [7] THE HUMAN MUC2 MUCIN APOPROTEIN APPEARS TO DIMERIZE BEFORE O-GLYCOSYLATION AND SHARES EPITOPES WITH THE INSOLUBLE MUCIN OF RAT SMALL-INTESTINE
    ASKER, N
    BAECKSTROM, D
    AXELSSON, MAB
    CARLSTEDT, I
    HANSSON, GC
    [J]. BIOCHEMICAL JOURNAL, 1995, 308 : 873 - 880
  • [8] O-glycosylated MUC2 monomer and dimer from LS 174T cells are water-soluble, whereas larger MUC2 species formed early during biosynthesis are insoluble and contain nonreducible intermolecular bonds
    Axelsson, MAB
    Asker, N
    Hansson, GC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (30) : 18864 - 18870
  • [9] Phase 3 Randomized Study of the Efficacy and Safety of Inhaled Dry Powder Mannitol for the Symptomatic Treatment of Non-Cystic Fibrosis Bronchiectasis
    Bilton, Diana
    Daviskas, Evangelia
    Anderson, Sandra D.
    Kolbe, John
    King, Gregory
    Stirling, Rob G.
    Thompson, Bruce R.
    Milne, David
    Charlton, Brett
    [J]. CHEST, 2013, 144 (01) : 215 - 225
  • [10] Cystic fibrosis: a disease of vulnerability to airway surface dehydration
    Boucher, Richard C.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2007, 13 (06) : 231 - 240